reported side effects of palifermin
arthralgia
dysesthesia
edema
hyperesthesia
hypoesthesia
serum amylase
paresthesia
pruritus
skin rash
tongue edema
dysgeusia
erythema
mouth discoloration
tongue discoloration
comprehensive list of adverse effects
needed effects
palifermin
unwanted side effects
medical attention
following side effects
taking palifermin
check
doctor
nurse
palifermin side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
dermatologic side effects for palifermin in relation
placebo therapy
rash
pruritus
erythema
).
skin rash
common serious side effect
clinical studies
n =-rrb-
occurrence of grade skin rash in patients
palifermin
placebo
resulting in the discontinuation of treatment in patients
palifermin
placebo
following
first consecutive days of administration
median time
cutaneous side effects
days with a median duration of days
following
first consecutive days of administration
median time
cutaneous side effects
including edema
days with a median duration of days
other side effects for palifermin in relation
placebo therapy
edema
pain
fever
perianal pain
).
other side effects of palifermin
single mcg/kg
dose
fatigue
headache
gastrointestinal side effects for palifermin in relation
placebo therapy
mouth/tongue thickness
discoloration
altered taste
).
oral/perioral dysesthesia
white film coating of the mouth
tongue
musculoskeletal side effects for palifermin in relation
placebo therapy
arthralgia
dysthesias in palifermin
treated patients
perioral region
contrast
patients
receiving placebo
reported dysthesias in extremities
nervous system
side effects for palifermin in relation
placebo therapy
dysthesias
).
types of dysthesias
hyperesthesia
hypoesthesia
paresthesia
available data on the effects of palifermin on stimulation of kgf receptor
expressing
hematopoietic tumors in patients
concentrations
times
average therapeutic human concentration palifermin
growth of human epithelial tumor cell lines
nude mouse xenograft models
doses
times
recommended human dose
consecutive weeks
weeks
dose-dependent increase in the growth rate
kgf receptor
expressing
expressing human tumor cell lines
oncologic side effects
enhancement in the growth of human epithelial tumor cell lines
increase in the rate of tumor cell line growth in a human carcinoma xenograft model
clinical studies
elevated serum lipase
amylase levels
peak increases
period of cytotoxic therapy
levels
baseline by the day of pbpc infusion
reports of required treatment intervention
increased amount of amylase
origin
metabolic side effects for palifermin in relation
placebo therapy
elevated serum lipase grade
elevated serum lipase grade
elevated serum amylase grade
elevated serum amylase grade
).
cardiovascular
side effects
hypertension
hypertension
doses of mcg/kg
mcg/kg in patients
undergoing hematopoietic transplantation
effect
reports of treatment discontinuation
hypertension
been reports
greater proteinuria in patients
palifermin
causal relationship between palifermin
proteinuria
genitourinary side effects
proteinuria
doses of mcg/kg
doses
doses after myeloablative chemotherapy/tbi
same type of side effects
mcg/kg doses
higher level of severity
higher dose
respiratory side effects for palifermin in relation
placebo therapy
cough
rhinitis
).
side effects of palifermin
fda
healthcare professional for medical advice
fever
skin rash (severe)
taste
blurred vision
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
change in taste
difficulty with moving
discoloration of the tongue
dizziness
flushing
redness of the skin
headache
increased sensitivity
pain
increased sensitivity
itching skin
muscle pain
stiffness
nervousness
pain
pain in the joints
pounding in the ears
rash (mild)
fast heartbeat
swelling
thickening of the tongue
tingling in the hands
feet
unusually warm skin
redness
swelling of the vagina
redness
swelling
pain of the skin
scaling of the skin on the hands
feet
ulceration of the skin